Invention Grant
- Patent Title: Treatment of CRTH2-mediated diseases and conditions
- Patent Title (中): 治疗CRTH2介导的疾病和病症
-
Application No.: US12232445Application Date: 2008-09-17
-
Publication No.: US08163936B2Publication Date: 2012-04-24
- Inventor: David Middlemiss , Mark Richard Ashton , Edward Andrew Boyd , Frederick Arthur Brookfield , Michael George Hunter , Mark Whittaker , Chris Palmer , Eric R. Pettipher
- Applicant: David Middlemiss , Mark Richard Ashton , Edward Andrew Boyd , Frederick Arthur Brookfield , Michael George Hunter , Mark Whittaker , Chris Palmer , Eric R. Pettipher
- Applicant Address: GB Abingdon, Oxon
- Assignee: Oxagen Limited
- Current Assignee: Oxagen Limited
- Current Assignee Address: GB Abingdon, Oxon
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: GB0324763.2 20031023
- Main IPC: C07D215/38
- IPC: C07D215/38
Abstract:
The present invention provides indole derivatives that antagonize prostaglandin D2, and that can be used to treat inflammatory diseases mediated by prostaglandin D2.
Public/Granted literature
- US20090018338A1 Treatment of CRTH2-Mediated diseases and conditions Public/Granted day:2009-01-15
Information query
